SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-13-001159
Filing Date
2013-05-15
Accepted
2013-05-15 16:29:13
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 biostar10q033113.htm 10-Q 777900
2 ex31-1.htm EX-31.1 15578
3 ex31-2.htm EX-31.2 15790
4 ex32-1.htm EX-32.1 6586
5 ex32-2.htm EX-32.2 7196
  Complete submission text file 0001185185-13-001159.txt   4565540

Data Files

Seq Description Document Type Size
6 bspm-20130331.xml EX-101.INS 731623
7 bspm-20130331.xsd EX-101.SCH 41341
8 bspm-20130331_cal.xml EX-101.CAL 32253
9 bspm-20130331_def.xml EX-101.DEF 201835
10 bspm-20130331_lab.xml EX-101.LAB 277702
11 bspm-20130331_pre.xml EX-101.PRE 211678
Mailing Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046
Business Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046 011-86-29-33686638
Biostar Pharmaceuticals, Inc. (Filer) CIK: 0001418133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34708 | Film No.: 13847585
SIC: 2834 Pharmaceutical Preparations